Cargando…
Regulation of B cell functions by S-nitrosoglutathione in the EAE model
B cells play both protective and pathogenic roles in T cell-mediated autoimmune diseases by releasing regulatory vs. pathogenic cytokines. B cell-depleting therapy has been attempted in various autoimmune diseases but its efficacy varies and can even worsen symptoms due to depletion of B cells relea...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246645/ https://www.ncbi.nlm.nih.gov/pubmed/34175668 http://dx.doi.org/10.1016/j.redox.2021.102053 |
_version_ | 1783716353551630336 |
---|---|
author | Kim, Judong Islam, S.M. Touhidul Qiao, Fei Singh, Avtar K. Khan, Mushfiquddin Won, Jeseong Singh, Inderjit |
author_facet | Kim, Judong Islam, S.M. Touhidul Qiao, Fei Singh, Avtar K. Khan, Mushfiquddin Won, Jeseong Singh, Inderjit |
author_sort | Kim, Judong |
collection | PubMed |
description | B cells play both protective and pathogenic roles in T cell-mediated autoimmune diseases by releasing regulatory vs. pathogenic cytokines. B cell-depleting therapy has been attempted in various autoimmune diseases but its efficacy varies and can even worsen symptoms due to depletion of B cells releasing regulatory cytokines along with B cells releasing pathogenic cytokines. Here, we report that S-nitrosoglutathione (GSNO) and GSNO-reductase (GSNOR) inhibitor N6022 drive upregulation of regulatory cytokine (IL-10) and downregulation of pathogenic effector cytokine (IL-6) in B cells and protected against the neuroinflammatory disease of experimental autoimmune encephalomyelitis (EAE). In human and mouse B cells, the GSNO/N6022-mediated regulation of IL-10 vs. IL-6 was not limited to regulatory B cells but also to a broad range of B cell subsets and antibody-secreting cells. Adoptive transfer of B cells from N6022 treated EAE mice or EAE mice deficient in the GSNOR gene also regulated T cell balance (Treg > Th17) and reduced clinical disease in the recipient EAE mice. The data presented here provide evidence of the role of GSNO in shifting B cell immune balance (IL-10 > IL-6) and the preclinical relevance of N6022, a first-in-class drug targeting GSNOR with proven human safety, as therapeutics for autoimmune disorders including multiple sclerosis. |
format | Online Article Text |
id | pubmed-8246645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82466452021-07-06 Regulation of B cell functions by S-nitrosoglutathione in the EAE model Kim, Judong Islam, S.M. Touhidul Qiao, Fei Singh, Avtar K. Khan, Mushfiquddin Won, Jeseong Singh, Inderjit Redox Biol Research Paper B cells play both protective and pathogenic roles in T cell-mediated autoimmune diseases by releasing regulatory vs. pathogenic cytokines. B cell-depleting therapy has been attempted in various autoimmune diseases but its efficacy varies and can even worsen symptoms due to depletion of B cells releasing regulatory cytokines along with B cells releasing pathogenic cytokines. Here, we report that S-nitrosoglutathione (GSNO) and GSNO-reductase (GSNOR) inhibitor N6022 drive upregulation of regulatory cytokine (IL-10) and downregulation of pathogenic effector cytokine (IL-6) in B cells and protected against the neuroinflammatory disease of experimental autoimmune encephalomyelitis (EAE). In human and mouse B cells, the GSNO/N6022-mediated regulation of IL-10 vs. IL-6 was not limited to regulatory B cells but also to a broad range of B cell subsets and antibody-secreting cells. Adoptive transfer of B cells from N6022 treated EAE mice or EAE mice deficient in the GSNOR gene also regulated T cell balance (Treg > Th17) and reduced clinical disease in the recipient EAE mice. The data presented here provide evidence of the role of GSNO in shifting B cell immune balance (IL-10 > IL-6) and the preclinical relevance of N6022, a first-in-class drug targeting GSNOR with proven human safety, as therapeutics for autoimmune disorders including multiple sclerosis. Elsevier 2021-06-23 /pmc/articles/PMC8246645/ /pubmed/34175668 http://dx.doi.org/10.1016/j.redox.2021.102053 Text en © 2021 The Authors. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Kim, Judong Islam, S.M. Touhidul Qiao, Fei Singh, Avtar K. Khan, Mushfiquddin Won, Jeseong Singh, Inderjit Regulation of B cell functions by S-nitrosoglutathione in the EAE model |
title | Regulation of B cell functions by S-nitrosoglutathione in the EAE model |
title_full | Regulation of B cell functions by S-nitrosoglutathione in the EAE model |
title_fullStr | Regulation of B cell functions by S-nitrosoglutathione in the EAE model |
title_full_unstemmed | Regulation of B cell functions by S-nitrosoglutathione in the EAE model |
title_short | Regulation of B cell functions by S-nitrosoglutathione in the EAE model |
title_sort | regulation of b cell functions by s-nitrosoglutathione in the eae model |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246645/ https://www.ncbi.nlm.nih.gov/pubmed/34175668 http://dx.doi.org/10.1016/j.redox.2021.102053 |
work_keys_str_mv | AT kimjudong regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel AT islamsmtouhidul regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel AT qiaofei regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel AT singhavtark regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel AT khanmushfiquddin regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel AT wonjeseong regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel AT singhinderjit regulationofbcellfunctionsbysnitrosoglutathioneintheeaemodel |